Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Schultz

Showing results (331-340 of 413) with videos related to

Pageof 42
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2023
Pharmacological YAP activation promotes regenerative repair of cutaneous woundsEdyta M Grzelak, N G R Dayan Elshan, Sida Shao, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2007
Small-molecule synergist of the Wnt/beta-catenin signaling pathwayQisheng Zhang, Michael B Major, Shinichi Takanashi, et al.
Genes & Development|November 1, 2016
Rapid dynamics of general transcription factor TFIIB binding during preinitiation complex assembly revealed by single-molecule analysisZhengjian Zhang, Brian P English, Jonathan B Grimm, et al.
Cell|June 11, 2013
Reshaping antibody diversityFeng Wang, Damian C Ekiert, Insha Ahmad, et al.
Angewandte Chemie (International Ed. in English)|July 25, 2014
Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemiaHua Lu, Quan Zhou, Vishal Deshmukh, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2011
Regenerative phenotype in mice with a point mutation in transforming growth factor beta type I receptor (TGFBR1)Jun Liu, Kristen Johnson, Jie Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2010
Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinomaAnna Dubrovska, Jimmy Elliott, Richard J Salamone, et al.
Nature|October 17, 2018
A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signallingMichael J Bollong, Gihoon Lee, John S Coukos, et al.
Bioconjugate Chemistry|May 7, 2015
Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug ConjugateReyna K V Lim, Shan Yu, Bo Cheng, et al.
Angewandte Chemie (International Ed. in English)|September 7, 2016
Multifunctional Antibody Agonists Targeting Glucagon-like Peptide-1, Glucagon, and Glucose-Dependent Insulinotropic Polypeptide ReceptorsYing Wang, Jintang Du, Huafei Zou, et al.
Pageof 42

Showing results (331-340 of 413) with videos related to

Sort By:
Pageof 42
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2023
Pharmacological YAP activation promotes regenerative repair of cutaneous woundsEdyta M Grzelak, N G R Dayan Elshan, Sida Shao, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2007
Small-molecule synergist of the Wnt/beta-catenin signaling pathwayQisheng Zhang, Michael B Major, Shinichi Takanashi, et al.
Genes & Development|November 1, 2016
Rapid dynamics of general transcription factor TFIIB binding during preinitiation complex assembly revealed by single-molecule analysisZhengjian Zhang, Brian P English, Jonathan B Grimm, et al.
Cell|June 11, 2013
Reshaping antibody diversityFeng Wang, Damian C Ekiert, Insha Ahmad, et al.
Angewandte Chemie (International Ed. in English)|July 25, 2014
Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemiaHua Lu, Quan Zhou, Vishal Deshmukh, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2011
Regenerative phenotype in mice with a point mutation in transforming growth factor beta type I receptor (TGFBR1)Jun Liu, Kristen Johnson, Jie Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2010
Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinomaAnna Dubrovska, Jimmy Elliott, Richard J Salamone, et al.
Nature|October 17, 2018
A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signallingMichael J Bollong, Gihoon Lee, John S Coukos, et al.
Bioconjugate Chemistry|May 7, 2015
Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug ConjugateReyna K V Lim, Shan Yu, Bo Cheng, et al.
Angewandte Chemie (International Ed. in English)|September 7, 2016
Multifunctional Antibody Agonists Targeting Glucagon-like Peptide-1, Glucagon, and Glucose-Dependent Insulinotropic Polypeptide ReceptorsYing Wang, Jintang Du, Huafei Zou, et al.
Pageof 42